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Solitary fibrous tumors (SFTs) was first differentiated from
mesothelioma by Klemperer and Rabin in 1931 [1], which
is an uncommon neoplasm of mesenchymal origin that
primarily affects the pleura and mediastinum. SFTs may
occur elsewhere in the body including respiratory tract,
peritoneum or mesentery, eyes, breasts and central nervous
system and other soft tissues. while liver parenchyma is a
rare location of SFT, with only 42 cases reported in the lit-
erature. Preoperative diagnosis for primary SFTs of liver is
difficult because of atypical symptom, and it mainly de-
pends on postoperative pathological examination. Because
four malignant transformation or metastasis cases has been
reported, the best surgical treatment is a complete resec-
tion including the edge of the tumor, and Long-term
follow-up is recommended. We herein report a case of
primary solitary fibrous tumor of liver and review the
previous reported cases, then discuss the possible differen-
tial diagnosis.
Case report
A 42-year-old male was admitted to the Department of
General Surgery with right upper abdomen pain for
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stated.fever, chill, jaundice and gastrointestinal bleeding. He de-
nied any history of surgery, blood transfusion, alcohol
abuse or medication. His vital signs (heart rate, blood
pressure, respiratory rate and body temperature) were
stable. Physical examination was unremarkable except
Murphy(+). Laboratory date were normal, except the
white blood cell (WBC) count was 13.79 × 109. Ultra-
sonography (US) revealed calculus of intrahepatic duct
(Figure 1). Magnetic resonance cholangiopancreatography
(MRCP) revealed Gallbladder calculi, cholecystitis and cal-
culus of intrahepatic duct (Figure 2). Based on the above
examinations, the preoperative diagnosis of calculus of
intrahepatic duct and acute cholecystitis was given.
At laparotomy, the gallbladder was slightly swollen
and high tension, which is 10 cm × 6 cm × 3 cm, espe-
cially gall bladder wall. An approximately 1.5 cm ×
1.0 cm × 1.0 cm nodule was found in left lateral lobe of
hepatic (Figure 3), so resection of the gallbladder and left
lateral lobe of hepatic was performed. pathological
examination of the resected specimen showed spindle
cell and fibroblast -like cells within the collagenous
stroma (Figures 4 and 5). Moreover, A clear demarcation
was found between the tumor edge area and normal liver
tissue (Figure 6), and the distribution of typical blood ves-
sel in the normal liver tissue (Figure 7). Immunohisto-
chemically, these spindle tumor cells showed diffuse CD34
and Bcl-2 positive reactivity (Figures 8 and 9), S-100 pro-
tein and HMB45 were negative, Masson colourationThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Figure 1 Ultrasonography (US) revealed calculus of
intrahepatic duct.
Figure 3 Gross appearance of the resected specimen, which
measured 1.5 cm × 1.0 cm × 1.0 cm in left lateral lobe
of hepatic.
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was uneventful, with hospital discharge at the eleventh
day. Although recurrence and metastasis was not seen, we
will pay attention to long-term follow-up.Discussion
Solitary fibrous tumors (SFTs) is an uncommon neo-
plasm of mesenchymal origin that primarily affects the
pleura and mediastinum. SFTs may occur elsewhere in
the body including respiratory tract, peritoneum or
mesentery, eyes, breasts and central nervous system and
other soft tissues. There are only 42 reported cases of
SFTs originating from the liver [2-35], and four of them
were malignant (Tables 1 and 2) [32-35].Figure 2 Magnetic resonance cholangiopancreatography
(MRCP) revealed Gallbladdercalculi and cholecystitis and
calculus of intrahepatic duct.SFTs is a form of borderline tumors, without potential
predisposing factors. SFT of the liver is more common
in women (26 cases were female in 42 patients), and
typically affects middle-aged adults (mean age 52, range
16–84) and it slowly grows with the performance of
local asymptomatic or abdominal pain, but occasional
cases have presented with hypoglycaemia. The corre-
sponding clinical symptoms appearance only when the
tumor grows to a certain size, or when vital structures
are involved. Although there are no definitive criteria of
malignancy for SFT, About 10% SFTs are malignant or
potentially malignant. The current World Health
Organization (WHO) classification criteria of soft tissue
tumors is used to identify malignant SFT, these criteria
include a large tumor size (more than 5 or 10 cm), aFigure 4 Histologic features of the lesion showed the tumor
was composed of small spindle cells, variably admixed with
fiber texture (HE × 100).
Figure 5 Higher magnification showing fiber texture and
spindle cells list storiform (HE × 400).
Figure 7 The distribution of typical blood vessel in the normal
liver tissue (HE × 200).
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clear pleomorphism, an area of tissue necrosis or
hemorrhage and an increased mitotic index (more than
4 mitoses in 10 HPFs) [35]. The patient suffered right
upper abdominal pain because of calculus of intrahepa-
tic duct, Gallbladder calculi, cholecystitis, and a nodule
was found in left lateral lobe of hepatic at laparotomy,
which led to the misdiagnose of calculus of intrahepatic
duct causing it. We resected the gallbladder and place-
holder nodules, postoperative pathology diagnosed
resected specimen as the occupying nodules solitary fi-
brous tumor.
Iconography examinations neither specifically diag-
nose SFTs nor identify the character of it, benign or
malignant. Generally speaking, if CT images show limit
isolated hyper vascular abnormal parceled tissue, we
will suspected the possibility of SFTs. The SFTs present
low signal in MRI scans because of mature fibrousFigure 6 A clear demarcation between the tumor edge area and
normal liver tissue (HE × 200).tissue T2WI in tumor [36]. In order to confirm the
diagnosis and assessment before operative, some scholars
have suggested percutaneous liver biopsy guided by radi-
ation. However, because this invasive procedures are only
conducted on tumor biopsy or part of the edge specimens,
if the tumor proliferates, it may be missed or misdiag-
nosed. In addition, due to its unclear nature, this proced-
ure may cause the risk of tumors growing along the
puncture path [37]. Therefore, for the diagnosis and as-
sessment of SFTs, percutaneous liver biopsy is not
recommended.
Although imaging examination will certainly help for
SFTs, but diagnosis of SFTs mostly depend on postoper-
ative pathological histological features and immunohis-
tochemical evaluation. General histological observation
can find that bland spindle cells arranged in a “pattern-
less” pattern, with alternating hypocellular and hyper-
cellular areas, interspersed with thick, “keloidal”Figure 8 Tumor cells showing diffuse immunohistochemical
positivity for CD-34.
Figure 9 Tumor cells showing diffuse immunohistochemical
positivity for Bcl-2.
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pattern is a common feature. Typical indicators of im-
munohistochemical revealed that CD34 and vimentin are
strongly positive, So is Bcl-2, which differentiate from
other tumors [14].
SFT should be differentiated from some other
haemangiopericytoma-like tumors: Haemangiopericy-
toma (HPC), synovial sarcoma, peripheral nerve sheath
tumor (PNST). HPC is most likely to be confused with
SFT in some other haemangiopericytoma-like tumors.
HPC is composed of spindle or oval shaped cells with
scanty cytoplasm and plump nucleus, which arrange
closely. The most important feature in HPC is extensive
irregular staghorn vascular pattern, Immunohistoche-
mistry tumor cells showed vimentin and actin focal
positivity and were negative for CD34 [38]. Other
haemangiopericytoma-like soft tissue tumors what
should be distinguished from SFT is synovial sarcoma.
It is a high-grade biphasic that characterized by epithe-
lioid and spindle cells with a solid growth pattern, Areas
of myxoid, neural, necrosis and a vasculature with nu-
merous dilated vessels resembling hemangiopericytoma
were observed. what is more, Immunohistochemical
studies for EMA and CK showed strong positivity, The
fusion gene SYT-SSX and translocation t(X; 18) are the
special marker for synovial sarcoma, which is not seen
in any other spindle cell tumors [39]. PNST is another
rare haemangiopericytoma-like soft tissue tumours that
may be confused with SFT. We can see the alternating
hypercellular area and hypocellular area, the spindle
cells form Wagner-Meissner structure, which makes the
spindle cell with wavy or pleomorphic nuclei and elon-
gated cytoplasmic. Intercellular substance has many
blood vessels, just as haemangiopericytoma-like forma-
tion. PNST is easy to become malignant tumour, which
high cellularity, nuclear atypia, and increased mitoticrate, necrosis, and endothelial proliferation can be
found [40]. Immunohistochemically, the tumor cells
were focally positive for S-100 protein, but negative for
desmin, CD34 and EMA.
There are only 42 reported cases of SFTs originating
from the liver, but it should be differentiated from some
other tumours originating from the liver. Among the pri-
mary neoplasms of the liver that can be confuse with SFTs
are Leiomyoma, Hepatic metastatic gastrointestinal stro-
mal tumors (GISTs), Hepatic angiomyolipoma (AML),
Sarcoma hepatocellular carcinoma (HCC) and Inflamma-
tory myofibroblastic tumour of the liver. Leiomyoma of
liver is a very rare tumor in liver. It consists of intersecting
bundles of smooth muscle cells with cigarshaped nuclei
that express MSA and SMA but not CD34 [14]. Gastro-
intestinal stromal tumors (GISTs) have a plentiful histo-
morphometric, and liver is the most common metastatic
part. Most hepatic metastatic GISTs is composed of spin-
dle and/or predominantly epithelioid cells with round to
oval-shaped nuclei and eosinophilic cytoplasm. We even
can see that the tumor cells proliferated in a diffuse or
sheetlike pattern with focal myxoid stroma and microcys-
tic change. About 95% are positive for KIT (CD117), 60–
70% for CD34, 30–40% for smooth muscle actin, while
cytokeratins and EMA are negative [41]. Angiomyolipoma
is commonly seen in the kidneys, but infrequently in liver.
These tumours are characterized by co-expression of
smooth muscle and melanocytic markers. Microscopically,
the tumours are composed of admixture of adipose tissue,
smooth muscle and blood vessels, The histological pat-
terns described include lipomatous, myomatous, angioma-
tous, trabecular, pelioid, inflammatory and mixed pattern,
and the cells were positive for HMB-45. Sarcoma hepato-
cellular carcinoma can be easily distinguished from SFT
by trabecular hepatocellular and sarcoma composition,
Immunohistochemistry demonstrates positivity for CK.
Inflammatory myofibroblastic tumour of the liver consists
of compact spindle cells (myofibroblasts, fibroblasts) inter-
mingled with inflammatory cells, predominantly plasma
cells, lymphocytes, as well as eosinophils. Immunohisto-
chemically, the tumor cells demonstrate positivity for
vimentin, MSA, SMA and cytokeratin [42].
Give that SFTs is a rare soft tissue tumor and occurs
most commonly in the pleura, there is need to make dif-
ferential diagnosis of SFTs in relationship to the pleura,
such as chronic organized pneumonia, pneumoconiosis,
pleural mesothelioma and some other uncommon pul-
monary tumor. Chronic organized pneumonia is the
most common disease of the lung and can be easily dif-
ferentiated from SFTs by its clinical presentation and
typical inflammatory exudation in pulmonary alveolus
cavity. Pneumoconiosis, including silicosis and asbestosis
of the lung, associated with occupational exposure to
silica and asbestos occur across a broad range of
Table 1 Clinical data of liver SFT in 42 patients previous reported in the literature
No Author Year Age/gender Treatment Lobe IH Follow-up
1 Edmondson 1958 16/F Excision R na 24 m
2 Edmondson 1958 na Excision R na na
3 Nevius 1959 56/M Radiation R na 2d
4 Ishak 1976 62/M Excision L na na
5 Ishak 1976 62/F Excision L na na
6 Kim 1983 27/F Excision L na 6 m
7 Kottke-Marchant 1989 84/F Excision L na 53 m
8 Barnoud 1996 50/M Excision R CD34+ 38 m
9 Levine 1997 57/M Excision L CD34+ na
10 Guglielmi 1998 61/F Excision R CD34+ 72 m
11 Moran 1998 62/F Excision na CD34+ na
12 Moran 1998 34/F no na na Autopsy
13 Moran 1998 57/F Excision na CD34+ na
14 Moran 1998 32/M Excision na CD34+ na
15 Moran 1998 68/F Excision na CD34+ 2d
16 Moran 1998 83/F Excision R CD34+ 6d
17 Moran 1998 72/F Excision L CD34+ 12 m
18 Moran 1998 62/F Excision L CD34+ na
19 Moran 1998 50/F Excision L CD34+ na
20 Fuksbrumer 2000 40/F Excision R CD34+ na
21 Fuksbrumer 2000 71/F Excision R CD34+ na
22 Fuksbrumer 2000 80/M Excision R CD34+ na
23 Yilmaz# 2000 25/F Excision R Vimentin+ 6 m
24 Lin 2001 75/M Excision R CD34+ 11 m
25 Saint-Marc 2002 69/F Excision R CD34+ 15 m
26 Neeff 2004 63/F Excision L CD34+ 11 m
27 Chithriki 2004 75/F Excision R CD34+ 6 m
28 Venarecci 2005 65/F Excision R CD34+ 30 m
29 Ji 2006 46/F Excision R CD34+ na
30 Lehmann 2006 63/F Excision R CD34+ 96 m
31 Nath 2006 65/F Excision R CD34+ 10 m
32 Terkivatan 2006 74/M Excision L CD34+ 12 m
33-35 Weitz 2007 na Excision na na na
36 Obuz 2007 52/M Excision L CD34+ 22 m
37 Perini 2007 40/F Excision L CD34+ 49 m
38 Chan# 2007 70/M Excision R CD34+ 12 m
39 F. Famà 2007 68/M Excision R CD34+ 25 m
40 Ka-Jeong Kim 2009 71/F Excision L CD34+ na
41 Brochard# 2010 54/M Excision R CD34+ 72 m
42 Peng L# 2011 24/F Excision R CD34+ 16 m
#malignant liver SFT; F, female; M, male; No, not operated; R, right; L, left; Na, not available; d, days; m, months; IH, Immunohistochemistry.
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Table 2 Summary of the 42 cases of liver SFT
Items Summarized date
Sex 26 female, 12 male, 4 na
Age(y) Range 16-84, average 52
Lobe 21R,13 L, 8 na
Treatment 40 excision, 1 radiation,1 no
Survial Range2d-96 m, average 48 m
Malignant 4 in 42 cases
F, female; M, male; No, not operated; R, right; L, left; Na, not available; Ms,
months; IH, Immunohistochemistry.
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nodule and diffuse pulmonary fibrosis [43], and asbes-
tosis is typical asbestos corpuscle, pleural plaques, dif-
fuse pleural thickening and pulmonary fibrosis [44],
which helps distinguish pneumoconiosis from SFTs of
lung. Pleural mesothelioma, mostly malignant, is asso-
ciated with the devolpment of pneumoconiosis. Ma-
lignant pleural mesothelioma (MPM) is divided into
three major histological sub-types: sarcomatoid bipha-
sic and epithelioid. Diffuse pleural thickening with
multiple nodular can be found and several immunohis-
tochemical panels are proposed to distinguish between
MPM and SFTs, such as strong positive for calretinin
and other useful antibodies include thrombomodulin,
mesothelin and cytokeratin 5 [45]. In addition, the
differential diagnosis should also include some uncom-
mon pulmonary tumor, such as Inflammatory myofi-
broblastic tumor (IMT) of lung, pulmonary sclerosing
hemangioma (PSH) and clear cell “sugar” tumor (CCST)
of lung. IMT of lung is a rare benign mesenchyma le-
sion which is closely related to recurrent respiratory
infections, Histologically, it shows the admixture of
spindle-shaped and ovoid cells with a prominent in-
flammatory infiltrate [46]. PSH is usually easily diag-
nosed based on the typical architectural patterns
including papillary, sclerotic, solid, hemorrhagic pat-
tern and the cuboidal cells or polygonal cells types
[47]. CCST of the lung is typically diagnosed by com-
puted tomography–guided transthoracic fine-needle
aspiration biopsy and core-needle biopsy, And cyto-
logic features is large irregular clusters of bland-
appearing polygonal and spindle-shaped cells with
vacuolated granular cytoplasm [48]. Besides, differen-
tial diagnosis of SFTs in abdominal cavity is gas-
trointestinal stromal tumors (GISTs) which we have
elaborated in preceding paragraph. And the differential
diagnosis of SFTs in soft tissue of shoulder and back
neck is spindle cell lipoma which is composed of spin-
dle cells, mature adipose tissue and varying amounts of
collagen fibers [49]. In additional, the SFTs of the hub,orbit and paranasal sinuses should be differentiated
from fibroblast cell meningioma, from which we can ob-
serve island meningeal skin cells and grit in the spindle-
shaped beam of tumor cells, and it can also be ruled out
by positive immunohistochemical staining for EMA, CK
and S-100 and negative staining for CD34 [50].
It was reported that a few non-islet cell tumor
hypoglycemia syndrome (NICTH) is associated with the
liver fibroma [51]. It has been foud that NICTH syn-
drome is related with the excess IGF-II (insulin-like
growth factor-II) tumor produces. Clinically that over-
production of IGF-II by solitary fibrous tumor of liver
led NICTH to be rarely reported, and the concrete
mechanism needs further study. But it remind us that
for those patients with persistent low blood sugar but
with normal islet cells for unknown reasons, if liver oc-
cupies, solitary fibrous tumor should be considered.Conclusion
There is no clear diagnostic criteria for SFT of liver, it
should be made by their microscopical and immunohisto-
chemical features. SFT of liver should be considered in the
differenial diagnosis of lesions with Haemangiopericy-
toma, synovial sarcoma, peripheral nerve sheath tumor
and some other tumours originating from the liver.
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